Page 1 of 1

Cladribine tablets for Multiple Sclerosis approved in Russia

PostPosted: Mon Jul 12, 2010 1:26 am

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that the Russian Federal Service on Surveillance in Healthcare and Social Development has become the first government agency to grant marketing approval to Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS).

Cladribine Tablets will be available in Russia under the trade name Movectro(R)..........Read More - ... ageid/1629